CME Group Inc. (NASDAQ:CME) Position Increased by Clear Creek Financial Management LLC

Clear Creek Financial Management LLC raised its stake in CME Group Inc. (NASDAQ:CME) by 4.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,378 shares of the financial services provider’s stock after buying an additional 107 shares during the period. Clear Creek Financial Management LLC’s holdings in CME Group were worth $525,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of CME. Capital International Investors lifted its holdings in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. boosted its holdings in shares of CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after buying an additional 1,309,097 shares during the period. M&G Plc acquired a new position in shares of CME Group in the first quarter worth about $156,631,000. Assenagon Asset Management S.A. increased its position in shares of CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after acquiring an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its position in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective on the stock. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Keefe, Bruyette & Woods upped their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Morgan Stanley increased their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Finally, Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $222.73.

Insider Transactions at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,221 shares of company stock worth $3,351,895 over the last three months. 0.30% of the stock is currently owned by insiders.

CME Group Stock Down 0.8 %

Shares of CME stock opened at $223.61 on Monday. The stock’s 50 day simple moving average is $220.69 and its 200 day simple moving average is $209.49. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $80.52 billion, a price-to-earnings ratio of 23.51, a PEG ratio of 5.67 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $2.25 EPS. CME Group’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, research analysts predict that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.06%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is currently 48.37%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.